Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹787 Cr₹-3,906 Cr₹-77 Cr₹-520 Cr₹-442 Cr

What is the latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLENMARK PHARMACEUTICALS is ₹787 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹787 Cr
Mar2024₹-3,906 Cr
Mar2023₹-77 Cr
Mar2022₹-520 Cr
Mar2021₹-442 Cr

How is Cash Flow from Financing Activities of GLENMARK PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹787 Cr
Positive
Mar2024 ₹-3,906 Cr
Negative
Mar2023 ₹-77 Cr
Negative
Mar2022 ₹-520 Cr
Negative
Mar2021 ₹-442 Cr -

Compare Cash Flow from Financing Activities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,657.9 Cr -0.6% -0.1% 0.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹474,396.0 Cr 1.8% 5.6% 16.7% Stock Analytics
DIVIS LABORATORIES ₹196,990.0 Cr 0.5% 13.1% 10.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,354.0 Cr -2.7% 5.1% 42.4% Stock Analytics
CIPLA ₹116,705.0 Cr 2.1% -0.6% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹94,790.0 Cr -4% -17.5% -8.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.6%

-0.1%

0.5%

SENSEX

-0.9%

-0.4%

-6.1%


You may also like the below Video Courses